Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
|Videos|August 13, 2022
Exciting Developments for Difficult to Treat Depression
Author(s)Michael E. Thase, MD
What are the latest treatments in difficult to treat depression?
Advertisement
Michael E. Thase, MD, gives a summary of his exciting talk on difficult to treat depression from the
Dr Thase is a professor of psychiatry at the Perelman School of Medicine University of Pennsylvania.
Advertisement
Related to this article
Advertisement
Advertisement